Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Current status of the Os-191. -->. Ir-191m generator

Technical Report ·
OSTI ID:5754763
The advantages of ultrashort-lived radionuclides for angiography have been well documented in recent years. Although several isotopes are potentially useful in this application (e.g., Au-195m, Ag-109m, Ir-191m), Ir-191m offers several advantages. Among these advantages are a parent isotope (Os-191) with a sufficiently long half-life (15.4 d) to allow production of a generator with a reasonable shelf-life, high photon yield (129 keV, 26%; 66 keV, 55%), and ease of production of the parent isotope (i.e., neutron irradiation of Os-190). Ir-191m has not, however, been widely used for radionuclide angiocardiography because of a less than optimal generator design and the assumption that the half-life of Ir-191m (4.96 s) was too short to permit visualization of the left ventricle in adult patients. Recently we have, however, been able to develop a generator with higher Ir-191m yield (25 to 30%/ml), lower Os-191 breakthrough (< 5 x 10/sup -4/%) that is easier to assemble. In addition, the eluate of this new generator (0.001M oxalic acid/0.9% saline) does not require buffering prior to injection. We have also demonstrated that adequate studies of the left ventricle can be obtained in adults when sufficient quantities of isotope are injected. 16 refs., 2 figs., 2 tabs.
Research Organization:
Children's Hospital Corp., Boston, MA (USA)
DOE Contract Number:
AC02-82ER60084
OSTI ID:
5754763
Report Number(s):
DOE/ER/60084-T2; ON: DE85008306
Country of Publication:
United States
Language:
English